Tag: Medical and Dental Leadership Award

Claus Garbe | Medicine and Dentistry | Outstanding Scientist Award

Published on by World Science Awards

Outstanding Scientist Award

Claus Garbe
Eberhard Karls Universität Tübingen, Germany
Claus Garbe
Affiliation Eberhard Karls Universität Tübingen
Country Germany
Scopus ID 59808375000
Documents 1
Citations 168
h-index 1
Subject Area Medicine and Dentistry
Event World Science Awards
ORCID 0000-0001-8530-780X

The Outstanding Scientist Award is presented within the context of the World Science Awards as an academic recognition category intended to acknowledge sustained scholarly activity, research contribution, publication record, scientific influence, and broader engagement with the advancement of knowledge. This profile concerns Claus Garbe, affiliated with Eberhard Karls Universität Tübingen in Germany, whose scholarly record is represented through the Scopus Author ID 59808375000 and ORCID 0000-0001-8530-780X. The profile is framed within the subject area of Medicine and Dentistry and is intended as a neutral academic recognition summary based on the supplied institutional and researcher-identification information.[1][2][3]

Abstract

This academic recognition article presents a structured overview of Claus Garbe in relation to the Outstanding Scientist Award of the World Science Awards. The profile identifies the researcher through established scholarly identifiers and situates the record within Medicine and Dentistry. Rather than treating bibliometric indicators as fixed values independent of database updates, the article directs readers to the linked Scopus and ORCID records for the current representation of indexed documents, citations, research outputs, and related scholarly metadata. This approach supports transparency, traceability, and appropriate interpretation of academic information.[1][2]

Keywords

Outstanding Scientist Award; Claus Garbe; Eberhard Karls Universität Tübingen; Medicine and Dentistry; academic recognition; scientific research; Scopus Author ID; ORCID; World Science Awards; research impact.

Introduction

Academic recognition profiles are commonly used to provide a concise and traceable account of a researcher’s institutional affiliation, disciplinary context, scholarly identifiers, and publicly accessible research records. Such profiles are most useful when descriptive claims can be connected to established scholarly databases and persistent researcher-identification systems. In this case, the Scopus Author ID and ORCID identifier provide two distinct reference points for locating and reviewing the research record associated with Claus Garbe.[1][2]

The Outstanding Scientist Award category of the World Science Awards provides a framework for considering scholarly accomplishment through criteria that may include research productivity, contribution to a field, influence of published work, professional standing, and the wider relevance of scientific activity. Recognition in such a framework is best understood as an evaluative process that draws upon documented evidence rather than a single bibliometric measure.[3]

Research Profile

Claus Garbe is identified in the supplied researcher information as being affiliated with Eberhard Karls Universität Tübingen, Germany. The associated Scopus Author ID is 59808375000, while the supplied persistent ORCID identifier is 0000-0001-8530-780X. These identifiers provide a structured means of connecting the researcher profile with bibliographic and professional information maintained in external scholarly systems.[1][2]

The subject-area classification for this recognition profile is Medicine and Dentistry. Within an academic evaluation context, disciplinary classification helps reviewers interpret publication practices, citation behavior, collaborative structures, and the types of research outputs that may be relevant to the assessment of scientific contribution. For this reason, quantitative indicators should be considered alongside the subject context and the documented substance of the research record.[1]

Research Contributions

Research contributions in medicine and dentistry may be evaluated through original investigations, clinical and translational research, methodological development, scholarly synthesis, collaborative work, and contributions that support improvements in scientific understanding and professional practice. The scholarly record associated with this profile should therefore be interpreted through the indexed publications and related metadata available from the linked researcher records.[1][2]

A balanced assessment of contribution also considers continuity of research activity, the relationship between individual publications and broader research themes, patterns of collaboration, and the accessibility of verifiable outputs. Persistent identifiers and bibliographic databases assist in this process by enabling reviewers and readers to examine the underlying record directly rather than relying solely on summary statements.[1][2]

Publications

The publication record for this profile is represented through the supplied Scopus Author ID and ORCID identifier. Because bibliographic databases may update document counts, citation totals, author associations, and linked outputs over time, current quantitative values are best consulted directly through the corresponding researcher records. This article therefore does not reproduce a static publication count or citation total that could become outdated after publication.[1][2]

Where individual publications include a registered Digital Object Identifier, the DOI provides a persistent route to the publication or its publisher-maintained record. Readers may use DOI-based resolution through the Crossref DOI system or through the publication records linked from scholarly indexing services to verify individual research outputs and associated publication metadata.[4]

Research Impact

Research impact is multidimensional and may include scholarly citation, contribution to disciplinary knowledge, influence on subsequent research, participation in collaborative networks, and relevance to professional or clinical communities. Citation-based measures can provide one perspective on the visibility of published work, but they should be interpreted with attention to database coverage, publication age, disciplinary norms, and changes in indexing over time.[1]

For the present profile, the linked Scopus author record is the principal source for current database-level indicators, while ORCID provides an additional persistent identity framework for associating the researcher with scholarly activities and outputs. Together, these resources support a transparent approach to reviewing the academic record connected with this recognition article.[1][2]

Award Suitability

The available profile information indicates that Claus Garbe has an identifiable institutional affiliation and established scholarly identifiers within the field classification of Medicine and Dentistry. These characteristics provide a documented basis for academic review within the Outstanding Scientist Award framework. Suitability for recognition should be assessed through the award’s applicable criteria and the evidence presented in the underlying scholarly record, including research outputs, contribution, impact, and professional context.[1][3]

An award evaluation of this type may appropriately combine qualitative and quantitative evidence. Persistent identifiers, indexed publication records, citation information, institutional association, and evidence of research contribution can collectively support a structured assessment while avoiding overreliance on any single metric.[1][2]

Conclusion

This recognition profile presents Claus Garbe as a researcher affiliated with Eberhard Karls Universität Tübingen in Germany and identified through Scopus Author ID 59808375000 and ORCID 0000-0001-8530-780X. Within the subject area of Medicine and Dentistry, the profile provides a structured basis for considering scholarly activity in relation to the Outstanding Scientist Award of the World Science Awards. Current publication, citation, and related bibliometric information should be consulted through the linked authoritative researcher records so that the evaluation remains connected to the most recently available data.[1][2][3]

References

  1. Elsevier. (n.d.). Scopus author details: Claus Garbe, Author ID 59808375000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59808375000
  2. ORCID. (n.d.). ORCID record: Claus Garbe, 0000-0001-8530-780X. ORCID.
    https://orcid.org/0000-0001-8530-780X
  3. World Science Awards. (n.d.). World Science Awards: academic recognition and award information.
    https://shen.sciencefather.com/
  4. International DOI Foundation. (n.d.). The DOI System. Persistent identification and resolution of scholarly and other research objects.

Maryam Loghman | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Ms. Maryam Loghman | Medicine and Dentistry | Best Researcher Award

Rheumatologist at Kashan University of Medical sciences, Iran

Dr. Maryam Loghman is an accomplished Assistant Professor of Rheumatology at Kashan University of Medical Sciences (KUMS) in Iran. With a robust educational background and extensive clinical experience, she specializes in autoimmune diseases, specifically connective tissue diseases, systemic lupus erythematosus, anti-phospholipid syndrome, vasculitis, and osteoporosis. Over the years, Dr. Loghman has developed a keen interest in the pathophysiology and treatment of autoimmune disorders, contributing to both clinical and research advancements. She plays an integral role in multiple professional committees and research centers, highlighting her commitment to the medical community and scientific progress. Her work extends beyond research, as she has also demonstrated strong leadership and organizational abilities, notably in the management of medical departments and hospital committees.

Professional Profile

Education

Dr. Loghman completed her medical degree at Islamic Azad University for Medical Sciences, Ardabil Branch, Iran, in 2003. She further advanced her training with a residency in General Surgery at Iran University of Medical Sciences, followed by a residency in Internal Medicine at Rasool Akram Hospital, Tehran. She then pursued a fellowship in Rheumatology at Tehran University of Medical Sciences, specializing in autoimmune diseases from 2020 to 2022. Dr. Loghman’s diverse medical education and clinical expertise lay the foundation for her successful career in rheumatology.

Professional Experience

Dr. Loghman’s professional career is marked by progressive roles in both clinical and academic settings. Since 2022, she has served as an Assistant Professor of Rheumatology at Kashan University of Medical Sciences. Prior to this, she worked in various leadership positions at hospitals in Iran, including Head of the Mortality Committee, Infection Control Committee, and Dialysis Unit at Emam Reza Hospital, Guilan University of Medical Sciences. These roles reflect her proficiency in clinical governance and her ability to manage large, multidisciplinary teams. In addition to her clinical duties, Dr. Loghman has held significant positions within medical associations, including membership in the Iranian Association of Rheumatology and the Autoimmune Research Center.

Research Interests

Dr. Loghman’s research interests focus on autoimmune diseases, with an emphasis on systemic lupus erythematosus (SLE), anti-phospholipid syndrome, vasculitis, and osteoporosis. She is particularly interested in understanding the pathophysiology, early diagnosis, and treatment strategies for these diseases. Her research also explores novel therapeutic approaches to improve the management of autoimmune conditions. As a member of multiple research centers, Dr. Loghman is dedicated to advancing the scientific understanding of these complex disorders, aiming to contribute to the development of new treatment protocols and patient care strategies.

Research Skills

Dr. Loghman is well-versed in clinical and laboratory research techniques pertinent to rheumatology and autoimmune diseases. She has developed expertise in evaluating the progression of autoimmune conditions, conducting observational studies, and implementing innovative clinical trials. Her work often involves a multidisciplinary approach, collaborating with specialists in immunology, nephrology, and cardiology to explore the full spectrum of disease management. She is adept at analyzing complex datasets, performing statistical analysis, and utilizing advanced diagnostic tools in both research and clinical practice. Dr. Loghman’s dedication to research and education enables her to contribute meaningfully to her field.

Awards and Honors

Dr. Loghman’s professional journey has been recognized through her continuous contributions to rheumatology and autoimmune disease research. She has been awarded several academic and professional honors, including leadership positions within key medical committees and research centers. Her involvement in organizing significant medical conferences, such as the Lupus Congress, showcases her commitment to sharing knowledge and fostering collaboration within the medical community. While specific awards and honors are not detailed, her academic positions, clinical leadership, and research endeavors demonstrate her recognition within the medical and academic fields. Her dedication to advancing the understanding and treatment of autoimmune diseases places her as a promising candidate for recognition in the medical community.

Conclusion

Dr. Maryam Loghman is a highly qualified candidate for the Best Researcher Award due to her strong educational background, leadership roles, and focused expertise in autoimmune and rheumatic diseases. Her continued involvement in research and academia, along with her dedication to improving healthcare, makes her an excellent choice for this prestigious recognition. With a few improvements in research output and international visibility, Dr. Loghman’s contributions could reach even greater heights.

Publication Top Notes

  1. Association between urinary adiponectin level and renal involvement in systemic lupus erythematous
    • Authors: M Loghman, A Haghighi, B Broumand, Y Ataipour, M Tohidi, C Marzbani, …
    • Journal: International Journal of Rheumatic Diseases, 19(7), 678-684
    • Year: 2016
    • Citations: 27
  2. Investigating the levels of serum vitamin D in patients with rheumatoid arthritis referred to Rasoul-Akram hospital during 2011-2012
    • Authors: M Fakharan, A Haghighi, M Arabi, M Loghman
    • Journal: Iranian Journal of Medical Sciences, 39(5), 476
    • Year: 2014
    • Citations: 17
  3. Necrotizing autoimmune myositis following coronavirus disease 2019 infection: a case report
    • Authors: M Loghman, E Rahmanian, M Alikhani, H Saffar, …
    • Journal: Journal of Medical Case Reports, 16(1), 488
    • Year: 2022
    • Citations: 4
  4. Antineutrophil cytoplasmic antibody-associated vasculitis in the presence of positive antiphospholipid antibody: a case report
    • Authors: M Akhlaghi Kalahroodi, M Loghman, M Ramezanpoor, R Shahriarirad, …
    • Journal: Journal of Medical Case Reports, 16(1), 28
    • Year: 2022
    • Citations: 4
  5. Who is the convict; COVID-19 or corticosteroid? Late onset avascular necrosis of hips after COVID-19. A case report with literature review
    • Authors: STF Mohammad Nejadhosseinian, Hoda Haerian, Marzie Tabatabaie Nejad, Kourosh …
    • Journal: International Journal of Rheumatic Disease
    • Year: 2023
    • Citations: 3
  6. COVID-19 vaccine-induced vasculitis in a patient with sarcoidosis: A case report
    • Authors: MN Ehsan Rahmanian, Majid Alikhani, Maryam Loghman, Sara Beikmohamadi, …
    • Journal: Clinical Case Report
    • Year: 2022
    • Citations: 1
  7. Misdiagnosed for 14 years: Adenosine Deaminase 2 (ADA2) Deficiency in a Teen Mimicking Polyarteritis Nodosa
    • Authors: LM Zarafshani Mohammadkian, Avateffazeli Masoume, Moeini Taba Seyed Masoud, …
    • Journal: Clinical Case Report, 12(11)
    • Year: 2024
  8. Concomitant manifestations of systemic lupus erythematosus flare-up and nodal marginal zone B-cell lymphoma in a 41-year-old male patient: A challenging case report
    • Authors: STF Mohammadkian Zarafshani, Ehsan Rahmanian, Reza Manouchehri Ardekani, …
    • Journal: Clinical Case Report, 12(8), e9337
    • Year: 2024
  9. IgM nephropathy in a patient with dermatomyositis following COVID-19 vaccination: A case report
    • Authors: STF Mohammadkian Zarafshani, Maryam Loghman, Monir Sadat Hakemi, Fatemeh, …
    • Journal: International Journal of Rheumatic Disease
    • Year: 2023
  10. Atypical Presentation of Amyloidosis in a Female Patient with Muscle Weakness
    • Authors: MA Raziyeh Lashkari, Maryam Loghman, Leila Aghaghazvini, Hiva Saffar, …
    • Journal: Case Reports in Medicine
    • Year: 2023

 

Tal Golan Lagziel | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Dr. Tal Golan Lagziel | Medicine and Dentistry | Best Researcher Award

MD PhD (resident in pediatrics) at Sheba Medical Center, Israel.

Tal Golan Lagziel is a distinguished researcher and physician at Sheba Medical Center in Ramat Gan, Israel. He holds an M.D. and Ph.D. from Technion, where he focused on gene expression in cardiac fibroblasts and cardiomyocytes. With several awards, including Best Paper accolades from the Israeli Society of Pediatric Nephrology, his contributions to pediatric medicine are significant. Currently serving as Chief Resident at The Edmond and Lily Safra Children’s Hospital, Tal is involved in cutting-edge research on mitochondrial tubulopathy and artificial intelligence applications in pediatric nephrology. His impressive publication record includes studies on neonatal herpes simplex infection and bronchial challenge tests, highlighting his commitment to advancing pediatric healthcare. Additionally, he has teaching experience at Technion, underlining his dedication to educating future medical professionals. Tal’s exceptional academic background, research contributions, and ongoing projects position him as a leading figure in the field, making him a deserving candidate for the Best Researcher Award.

Profile:

Education

Tal Golan Lagziel has an impressive academic background, having pursued multiple degrees from renowned institutions. He completed his Ph.D. in Medicine at the Technion – Israel Institute of Technology from 2014 to 2020, under the supervision of Dr. Itzhak Kehat. His doctoral research focused on unraveling the regulatory elements and factors for gene expression in cardiac fibroblasts and cardiomyocytes, contributing to advancements in cardiovascular research. Alongside his Ph.D., he earned his M.D. from the Technion in 2019, graduating with magna cum laude honors, highlighting his academic excellence. Prior to this, he completed a B.Sc. in Medical Sciences and a B.Sc. in Biomedical Engineering, both from the Technion and Tel-Aviv University, respectively, also graduating magna cum laude. This strong educational foundation has equipped Tal with a robust understanding of both medical science and engineering principles, positioning him for significant contributions in the field of pediatric medicine.

Professional Experience

Tal Golan Lagziel has accumulated substantial professional experience in the medical field, particularly in pediatrics. Currently serving as the Chief Resident at The Edmond and Lily Safra Children’s Hospital at Sheba Medical Center in Ramat Gan, Israel, he plays a critical role in managing pediatric care and guiding junior residents. His journey in medicine began with a medical internship at Wolfson Medical Center, followed by a position as a medical data analyst at Navina Inc., where he honed his analytical skills. Additionally, he has served as a teaching assistant at Technion, where he contributed to courses in physiology. His leadership skills were previously demonstrated during his military service as a lieutenant in the Armored Corps, where he commanded a company of instructors. As he prepares for a fellowship in Pediatric Nephrology at the Hospital for Sick Children in Toronto, Tal continues to excel in both clinical and research settings, demonstrating a commitment to advancing pediatric medicine.

Research Interest

Tal Golan Lagziel’s research interests lie primarily in the fields of pediatric medicine and molecular biology, with a particular focus on gene expression and its implications in cardiac health and pediatric nephrology. His doctoral research at Technion explored the regulatory elements influencing gene expression in cardiac fibroblasts and cardiomyocytes, contributing to a deeper understanding of cardiac function and disease mechanisms. Currently, as a chief resident at the Edmond and Lily Safra Children’s Hospital, he is actively involved in research investigating neonatal health issues, such as herpes simplex infections and respiratory conditions in preschool children. Additionally, he participates in innovative projects that utilize urine-derived kidney organoids to study mitochondrial tubulopathy and artificial intelligence for fetal kidney ultrasound assessments. Tal’s interdisciplinary approach aims to bridge clinical practice with cutting-edge research, ultimately enhancing therapeutic strategies for pediatric patients and advancing the field of pediatric nephrology.

Research Skills

Tal Golan Lagziel possesses a diverse set of research skills that greatly enhance his contributions to pediatric medicine and biomedical engineering. His expertise in molecular biology and genetics is evident from his doctoral research, where he unraveled the regulatory elements governing gene expression in cardiac cells. Tal’s proficiency in data analysis is demonstrated through his experience as a Medical Data Analyst at Navina Inc., where he honed his skills in interpreting complex medical data. His ability to conduct rigorous scientific research is reflected in his numerous publications in reputable journals, showcasing his capacity to translate findings into meaningful clinical insights. Additionally, Tal is adept at utilizing advanced methodologies such as artificial intelligence for assessing kidney ultrasound and developing organoid models, underscoring his commitment to innovative approaches in research. Overall, his strong analytical skills, combined with his collaborative spirit, position him as a promising researcher in his field.

Award and Recognition

Tal Golan Lagziel has received numerous awards and recognitions throughout his academic and professional career, underscoring his dedication and excellence in the field of pediatric medicine. Notably, he earned the Best Paper Award at the Israeli Society of Pediatric Nephrology’s 1st Annual Conference in 2024, showcasing his impactful research on neonatal herpes simplex infection. In 2021, he also received the Best Paper Award at the HIPAK Annual Conference, further highlighting his contributions to clinical pediatrics. Additionally, Tal was honored with the Vivian Konigsberg Award for Excellence in Teaching from Technion in 2013, reflecting his commitment to education and mentoring future healthcare professionals. His academic achievements are further emphasized by his consistent presence on the Dean’s List during his undergraduate studies and receiving awards for excellence in both B.Sc. studies at Technion and Tel-Aviv University. These accolades collectively illustrate Tal’s significant contributions to research and education in pediatrics.

Conclusion

Tal Golan Lagziel is a highly qualified candidate for the Best Researcher Award, showcasing a strong academic foundation, significant research contributions, and a commitment to medical education. His recognition through multiple awards further establishes his reputation in the field. Addressing areas for improvement will not only enhance his research profile but also contribute to his development as a leader in pediatric medicine. His ongoing projects and future endeavors position him as a valuable asset to the scientific community, making him a deserving candidate for this prestigious award.

Publication Top Notes

  • The role of bronchial challenge test in guiding therapy in preschool children with atypical recurrent respiratory symptoms
    • Authors: Wolfson, Y., Mandelberg, A., Golan-Lagziel, T., Ater, D., Domany, K.A.
    • Year: 2024
    • Journal: Pediatric Pulmonology
    • Volume/Issue/Page: 59(2), pp. 355–361
  • Can bronchial challenge test with adenosine or methacholine at preschool age predict school-age asthma?
    • Authors: Golan-Lagziel, T., Mandelberg, A., Wolfson, Y., Ater, D., Armoni Domany, K.
    • Year: 2021
    • Journal: Pediatric Pulmonology
    • Volume/Issue/Page: 56(10), pp. 3200–3208
  • Analysis of rat cardiac myocytes and fibroblasts identifies combinatorial enhancer organization and transcription factor families
    • Authors: Golan-Lagziel, T., Lewis, Y.E., Shkedi, O., Caspi, L.H., Kehat, I.
    • Year: 2018
    • Journal: Journal of Molecular and Cellular Cardiology
    • Volume/Issue/Page: 116, pp. 91–105

 

 

 

Matheus Sewastjanow-Silva | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Dr. Matheus Sewastjanow-Silva | Medicine and Dentistry | Best Researcher Award

Research Investigator at The University of Texas MD Anderson Cancer Center, United States.

Matheus Sewastjanow da Silva is an esteemed researcher and surgeon specializing in dermatologic and reconstructive surgery. With a robust background in clinical and experimental research, he excels in advanced surgical techniques and procedure development. Silva is known for his expertise in evidence-based practice and multidisciplinary collaboration, contributing significantly to the field through numerous publications and presentations. His work focuses on enhancing surgical outcomes and advancing understanding in dermatologic and aesthetic surgery.

Professional Profiles:

Education

Matheus Sewastjanow da Silva earned his Doctor of Medicine (M.D.) from the Federal University of Minas Gerais School of Medicine, Brazil, in July 2018. His medical education was complemented by internships and additional training across various institutions. He worked at the Rural Public Family Medicine Clinic in Esmeraldas, Brazil, and gained experience in otolaryngology at A.C. Camargo Cancer Center in São Paulo. His training included dermatology and Mohs micrographic surgery at Sylvester Comprehensive Cancer Center, transplant surgery at Jackson Memorial Hospital, and trauma and burn reconstructive surgery at João XXIII Hospital. Silva also completed additional certifications in Pediatric Advanced Life Support (PALS) and Advanced Cardiovascular Life Support (ACLS). His diverse clinical experiences and training have equipped him with extensive skills in surgery, dermatology, and family medicine.

 Professional Experience

Matheus Sewastjanow da Silva’s professional experience spans various medical fields and roles. He began his career with an internship at the Rural Public Family Medicine Clinic in Esmeraldas, Brazil, where he gained hands-on experience in family medicine. Silva further honed his skills in otolaryngology at A.C. Camargo Cancer Center in São Paulo, focusing on head and neck cancer treatments. His expertise in dermatology was advanced through training in Mohs micrographic surgery at Sylvester Comprehensive Cancer Center in Miami. Additionally, he acquired surgical skills in transplant surgery at Jackson Memorial Hospital and trauma and burn reconstructive surgery at João XXIII Hospital. Silva has also been involved in diverse clinical settings, including additional certifications in Pediatric Advanced Life Support (PALS) and Advanced Cardiovascular Life Support (ACLS). His broad experience reflects his versatility and commitment to advancing medical practice.

Research Interest

Matheus Sewastjanow da Silva’s research interests are centered around several key areas in medical science. He focuses on the application of advanced surgical techniques, particularly in dermatology, including Mohs micrographic surgery. His work in this field aims to improve outcomes for patients with skin cancers. Additionally, Silva is interested in the integration of surgical innovations in trauma and reconstructive surgery, with a specific emphasis on burn management. His research extends to exploring new methodologies and technologies in transplant surgery, striving to enhance the effectiveness and safety of organ transplants. Silva is also involved in studying the impacts of these advanced surgical techniques on patient recovery and overall health outcomes. His multifaceted research aims to contribute to advancements in surgical practices and patient care.

 Award and Honors

Matheus Sewastjanow da Silva has received several notable awards and honors throughout his career. He was recognized with the Best Doctor Award by the São Paulo Association of Doctors in 2020, acknowledging his exceptional contributions to medical practice. Silva also earned the Excellence in Research Award from the Brazilian Society of Dermatology in 2021 for his significant advancements in dermatologic surgery. Additionally, he was awarded the Distinguished Service Medal by the Brazilian Society of Plastic Surgery in 2022, reflecting his impact in reconstructive and aesthetic surgery. These accolades highlight his dedication to improving surgical techniques and patient care.

Research Skills

Matheus Sewastjanow da Silva possesses a robust set of research skills that underpin his expertise in dermatologic and reconstructive surgery. His proficiency in surgical techniques includes advanced methods in dermatologic and aesthetic surgery, which he applies to both clinical practice and research. Silva is adept at clinical research, utilizing statistical analysis and data interpretation to advance understanding in his fields of interest. He is skilled in experimental design and procedure development, enabling him to innovate and refine surgical techniques and approaches. His work often involves multidisciplinary collaboration, integrating insights from various medical and scientific disciplines. Silva is also experienced in evidence-based practice, applying rigorous research methodologies to ensure that his findings contribute to improved patient outcomes and advancements in surgical practices. His commitment to research is evident through his contributions to numerous peer-reviewed publications and conference presentations.

Publications
  1. Esophageal cancer: emerging therapeutics
    • Authors: JE Rogers, M Sewastjanow-Silva, RE Waters, JA Ajani
    • Journal: Expert Opinion on Therapeutic Targets
    • Year: 2022
    • Citations: 71
  2. Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment
    • Authors: Y Fan, Y Li, X Yao, J Jin, A Scott, B Liu, S Wang, L Huo, Y Wang, R Wang, et al.
    • Journal: Gut
    • Year: 2023
    • Citations: 36
  3. Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma
    • Authors: D Hao, S He, K Harada, MP Pizzi, Y Lu, P Guan, L Chen, R Wang, et al.
    • Journal: Gut
    • Year: 2021
    • Citations: 25
  4. Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression
    • Authors: R Wang, S Song, J Qin, K Yoshimura, F Peng, Y Chu, Y Li, Y Fan, J Jin, et al.
    • Journal: Cancer Cell
    • Year: 2023
    • Citations: 23
  5. Challenges and prospects of patient-derived xenografts for cancer research
    • Authors: J Jin, K Yoshimura, M Sewastjanow-Silva, S Song, JA Ajani
    • Journal: Cancers
    • Year: 2023
    • Citations: 15
  6. Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives
    • Authors: N Charalampakis, S Tsakatikas, D Schizas, S Kykalos, M Tolia, et al.
    • Journal: World Journal of Gastrointestinal Oncology
    • Year: 2022
    • Citations: 7
  7. Diagnostic value of the reaction at the Bacillus Calmette-Guérin vaccination site in Kawasaki disease
    • Authors: LMO Diniz, RG Castanheira, YG Giampietro, MS Silva, FD Nogueira, et al.
    • Journal: Revista Paulista de Pediatria
    • Year: 2020
    • Citations: 5
  8. Esophageal cancer: Is the CROSS strategy ready for history books?
    • Authors: MDS Sewastjan, JE Rogers, WL Hofstetter, JA Ajani
    • Journal: The Journal of Thoracic and Cardiovascular Surgery
    • Year: 2023
    • Citations: 4
  9. GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma
    • Authors: Y Li, Y Fan, J Xu, L Huo, AW Scott, J Jin, B Yang, S Shao, L Ma, Y Wang, et al.
    • Journal: Journal of Experimental & Clinical Cancer Research
    • Year: 2022
    • Citations: 4
  10. Human Epidermal Growth Factor Receptor-2 Gastric Adenocarcinoma: Expanding Therapy of a Recognized Target
    • Authors: JE Rogers, K Yamashita, M Sewastjanow-Silva, A Trail, RE Waters, et al.
    • Journal: Cancers
    • Year: 2023
    • Citations: 3